Cargando…

Metabolism in Cancer Stem Cells: Targets for Clinical Treatment

Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Gui-Min, Xu, Xiao-Yan, Xia, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736883/
https://www.ncbi.nlm.nih.gov/pubmed/36497050
http://dx.doi.org/10.3390/cells11233790
_version_ 1784847145515352064
author Wen, Gui-Min
Xu, Xiao-Yan
Xia, Pu
author_facet Wen, Gui-Min
Xu, Xiao-Yan
Xia, Pu
author_sort Wen, Gui-Min
collection PubMed
description Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming refers to the metabolic changes that occur when tumor cells provide sufficient energy and nutrients for themselves. Metabolic reprogramming plays an important role in regulating the growth and activity of cancer cells and cancer stem cells. In addition, the immune cells or stromal cells in the tumor microenvironment (TME) will change due to the metabolic reprogramming of cancer cells. Summarizing the characteristics and molecular mechanisms of metabolic reprogramming of cancer stem cells will provide new ideas for the comprehensive treatment of malignant tumors. In this review, we summarized the changes of the main metabolic pathways in cancer cells and cancer stem cells.
format Online
Article
Text
id pubmed-9736883
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97368832022-12-11 Metabolism in Cancer Stem Cells: Targets for Clinical Treatment Wen, Gui-Min Xu, Xiao-Yan Xia, Pu Cells Review Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming refers to the metabolic changes that occur when tumor cells provide sufficient energy and nutrients for themselves. Metabolic reprogramming plays an important role in regulating the growth and activity of cancer cells and cancer stem cells. In addition, the immune cells or stromal cells in the tumor microenvironment (TME) will change due to the metabolic reprogramming of cancer cells. Summarizing the characteristics and molecular mechanisms of metabolic reprogramming of cancer stem cells will provide new ideas for the comprehensive treatment of malignant tumors. In this review, we summarized the changes of the main metabolic pathways in cancer cells and cancer stem cells. MDPI 2022-11-26 /pmc/articles/PMC9736883/ /pubmed/36497050 http://dx.doi.org/10.3390/cells11233790 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wen, Gui-Min
Xu, Xiao-Yan
Xia, Pu
Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title_full Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title_fullStr Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title_full_unstemmed Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title_short Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
title_sort metabolism in cancer stem cells: targets for clinical treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736883/
https://www.ncbi.nlm.nih.gov/pubmed/36497050
http://dx.doi.org/10.3390/cells11233790
work_keys_str_mv AT wenguimin metabolismincancerstemcellstargetsforclinicaltreatment
AT xuxiaoyan metabolismincancerstemcellstargetsforclinicaltreatment
AT xiapu metabolismincancerstemcellstargetsforclinicaltreatment